好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Biomarkers for Parkinson’s Disease with Reflex Tears Correlate with Disease Duration
Movement Disorders
S17 - Parkinson's Disease Biomarkers and Pathophysiology (1:00 PM-1:12 PM)
001

To evaluate whether the protein composition of reflex tears differs in Parkinson’s disease (PD) patients stratified by disease duration versus Healthy controls (HC)

We have previously shown that oligomeric alpha synuclein is significantly elevated in both basal tears (anesthetized Schirmer’s test) and reflex tears (unanesthetized Schirmer’s test) in PD patients versus HC. Our patient sample was homogeneous related to disease duration. We have designed this study to evaluate the efficacy of collecting reflex tears to provide a true biomarker capable of differentiating PD progression compared to HC.  

Reflex tears were collected from 39 male and female early disease duration (0-4 years) ,                             26 intermediate (5-8 years), and 28 late disease duration (greater than 9 years) PD patients and 43 male and female HC using an unanesthetized Schirmer’s test. Samples were pooled from both eyes for analysis of oligomeric alpha-synuclein. Values were measured by ELISA and normalized to protein content of the sample.

Oligomeric alpha-synuclein was significantly increased by 8.6-fold in tears of early PD patients (4.43 ± 1.26 ng/mg tear protein, p-value<0.0001), 4.5 fold in tears of intermediate PD (2.3 ± 0.54 ng/mg tear protein, p-value=0.0006) and 3.7 fold in tears of late PD (1.9 ± 0.59 ng/mg tear protein, p-value=0.01) relative to HC (0.51 ± 0.15 ng/mg tear protein). No significant sex differences were present.

Oligomeric  alpha-synuclein levels in tear fluid may enable discrimination between various stages of PD patients based on disease duration compared to HC. The current study is conducted in an independent cohort compared to our previous studies and the results  1) validate previous findings that oligomeric alpha-synuclein levels are increased in reflex tears of PD patients compared to HC; and 2) suggest that elevations in oligomeric alpha-synuclein are more pronounced in patients with early stage than late stage PD.

Authors/Disclosures
Mark F. Lew, MD, FAAN (USC School of Medicine)
PRESENTER
Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
No disclosure on file
Danielle Feigenbaum, MD (Usc) Dr. Feigenbaum has nothing to disclose.
No disclosure on file
No disclosure on file
Wendy Mack No disclosure on file
No disclosure on file
No disclosure on file